Literature DB >> 24944490

Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma.

Gen Sugiyama1, Yoshinobu Okabe1, Yusuke Ishida1, Fumihiko Saitou1, Ryuichi Kawahara1, Hiroto Ishikawa1, Hiroyuki Horiuchi1, Hisafumi Kinoshita1, Osamu Tsuruta1, Michio Sata1.   

Abstract

AIM: To review the usefulness of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma and identify problems that may need to be addressed.
METHODS: The study population consisted of 36 patients with obstructive jaundice caused by hepatocellular carcinoma (HCC) who underwent endoscopic biliary stenting (EBS) as the initial drainage procedure at our hospital. The EBS technical success rate and drainage success rate were assessed. Drainage was considered effective when the serum total bilirubin level decreased by 50% or more following the procedure compared to the pre-drainage value. Survival time after the procedure and patient background characteristics were assessed comparatively between the successful drainage group (group A) and the non-successful drainage group (group B). The EBS stent patency duration in the successful drainage group (group A) was also assessed.
RESULTS: The technical success rate was 100% for both the initial endoscopic nasobiliary drainage and EBS in all patients. Single stenting was placed in 21 patients and multiple stenting in the remaining 15 patients. The drainage successful rate was 75% and the median interval to successful drainage was 40 d (2-295 d). The median survival time was 150 d in group A and 22 d in group B, with the difference between the two groups being statistically significant (P < 0.0001). There were no statistically significant differences between the two groups with respect to patient background characteristics, background liver condition, or tumor factors; on the other hand, the two groups showed statistically significant differences in patients without a history of hepatectomy (P = 0.009) and those that received multiple stenting (P = 0.036). The median duration of stent patency was 43 d in group A (2-757 d). No early complications related to the EBS technique were encountered. Late complications occurred in 13 patients (36.1%), including stent occlusion in 7, infection in 3, and distal migration in 3.
CONCLUSION: EBS is recommended as the initial drainage procedure for obstructive jaundice caused by HCC, as it appears to contribute to prolongation of survival time.

Entities:  

Keywords:  Biliary drainage; Endoscopic biliary stenting; Hepatocellular carcinoma; Obstructive jaundice; Percutaneous transhepatic biliary drainage

Mesh:

Substances:

Year:  2014        PMID: 24944490      PMCID: PMC4051939          DOI: 10.3748/wjg.v20.i22.6968

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

Review 1.  Hepatocellular carcinoma presenting with obstructive jaundice.

Authors:  Eric C H Lai; Wan Yee Lau
Journal:  ANZ J Surg       Date:  2006-07       Impact factor: 1.872

2.  Biliary drainage for obstructive jaundice caused by unresectable hepatocellular carcinoma: the endoscopic versus percutaneous approach.

Authors:  Jongkyoung Choi; Ji Kon Ryu; Sang Hyub Lee; Dong-Won Ahn; Jin-Hyeok Hwang; Yong-Tae Kim; Yong Bum Yoon; Joon Koo Han
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2012-12-15

3.  Single-session endoscopic bilateral y-configured placement of metal stents for hilar malignant biliary obstruction.

Authors:  Yoshihide Kanno; Kei Ito; Naotaka Fujita; Yutaka Noda; Go Kobayashi; Takashi Obana; Jun Horaguchi; Osamu Takasawa; Yuhei Kato; Shinsuke Koshita; Yasunobu Yamashita; Takahisa Ogawa
Journal:  Dig Endosc       Date:  2011-01       Impact factor: 7.559

4.  A logical approach to hepatocellular carcinoma presenting with jaundice.

Authors:  W Lau; K Leung; T W Leung; C T Liew; M S Chan; S C Yu; A K Li
Journal:  Ann Surg       Date:  1997-03       Impact factor: 12.969

5.  Management of hepatocellular carcinoma presenting as obstructive jaundice.

Authors:  W Y Lau; J W Leung; A K Li
Journal:  Am J Surg       Date:  1990-09       Impact factor: 2.565

6.  Obstructive jaundice secondary to hepatocellular carcinoma.

Authors:  W Y Lau; K L Leung; T W Leung; S Ho; M Chan; C K Liew; N Leung; P Johnson; A K Li
Journal:  Surg Oncol       Date:  1995       Impact factor: 3.279

7.  Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors.

Authors:  M Ducreux; C Liguory; J F Lefebvre; O Ink; A Choury; J Fritsch; D Bonnel; S Derhy; J P Etienne
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

8.  Percutaneous trans-hepatic bilateral biliary stenting in Bismuth IV malignant obstruction.

Authors:  Dimitrios Karnabatidis; Stavros Spiliopoulos; Paraskevi Katsakiori; Odissefs Romanos; Konstantinos Katsanos; Dimitrios Siablis
Journal:  World J Hepatol       Date:  2013-03-27

9.  Effect of endoscopic stenting of malignant bile duct obstruction on quality of life.

Authors:  Olga Barkay; Patrick Mosler; Colleen M Schmitt; Glen A Lehman; James T Frakes; John F Johanson; Tahir Qaseem; Douglas A Howell; Stuart Sherman
Journal:  J Clin Gastroenterol       Date:  2013-07       Impact factor: 3.062

10.  Cholangiographic features in the diagnosis and management of obstructive icteric type hepatocellular carcinoma.

Authors:  W Y Lau; C K Leow; K L Leung; T W Leung; M Chan; S C Yu
Journal:  HPB Surg       Date:  2000
View more
  4 in total

1.  Percutaneous intraductal radiofrequency ablation for treatment of biliary stent occlusion: A preliminary result.

Authors:  Ning Xia; Ju Gong; Jian Lu; Zhi-Jin Chen; Li-Yun Zhang; Zhong-Min Wang
Journal:  World J Gastroenterol       Date:  2017-03-14       Impact factor: 5.742

Review 2.  Infections in Cancer Patients with Solid Tumors: A Review.

Authors:  Kenneth V I Rolston
Journal:  Infect Dis Ther       Date:  2017-02-03

3.  Role of endoscopic biliary drainage in advanced hepatocellular carcinoma with jaundice.

Authors:  Hyun Young Woo; Sung Yong Han; Jeong Heo; Dong Uk Kim; Dong Hoon Baek; So Yong Yoo; Chang Won Kim; Suk Kim; Geun Am Song; Mong Cho; Dae Hwan Kang
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

4.  Effectiveness, safety, and factors associated with the clinical success of endoscopic biliary drainage for patients with hepatocellular carcinoma: a retrospective multicenter study.

Authors:  Akihiro Matsumi; Hironari Kato; Toru Ueki; Etsuji Ishida; Masahiro Takatani; Masakuni Fujii; Masaki Wato; Tatsuya Toyokawa; Ryo Harada; Hirofumi Tsugeno; Minoru Matsubara; Hiroshi Matsushita; Hiroyuki Okada
Journal:  BMC Gastroenterol       Date:  2021-01-13       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.